These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 1378472)

  • 21. In vitro mutagenesis of HLA-B27. Amino acid substitutions at position 67 disrupt anti-B27 monoclonal antibody binding in direct relation to the size of the substituted side chain.
    el-Zaatari FA; Sams KC; Taurog JD
    J Immunol; 1990 Feb; 144(4):1512-7. PubMed ID: 1689355
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A new monoclonal antibody recognizing a linear determinant on the HLA-DRalpha chain N-terminus.
    Ting YT; Temme S; Koch N; McLellan AD
    Hybridoma (Larchmt); 2009 Dec; 28(6):423-9. PubMed ID: 20025501
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibodies to HLA-E may account for the non-donor-specific anti-HLA class-Ia antibodies in renal and liver transplant recipients.
    Ravindranath MH; Pham T; Ozawa M; Terasaki PI
    Int Immunol; 2012 Jan; 24(1):43-57. PubMed ID: 22190577
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mapping of an assembled epitope of human follicle-stimulating hormone-beta utilizing monoclonal antibodies, synthetic peptides, and hormone-receptor inhibition.
    Vakharia DD; Dias JA; Thakur AN; Andersen TT; O'Shea A
    Endocrinology; 1990 Aug; 127(2):658-66. PubMed ID: 1695567
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epitope specificity of 30 monoclonal antibodies against cytokeratin antigens: the ISOBM TD5-1 Workshop.
    Stigbrand T; Andrés C; Bellanger L; Bishr Omary M; Bodenmüller H; Bonfrer H; Brundell J; Einarsson R; Erlandsson A; Johansson A; Leca JF; Levi M; Meier T; Nap M; Nustad K; Seguin P; Sjödin A; Sundström B; van Dalen A; Wiebelhaus E; Wiklund B; Arlestig L; Hilgers J
    Tumour Biol; 1998; 19(2):132-52. PubMed ID: 9486565
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monoclonal antibodies against synthetic sequences of the nicotinic receptor cross-react fully with the native receptor and reveal the transmembrane disposition of their epitopes.
    Lei S; Raftery MA; Conti-Tronconi BM
    Biochemistry; 1993 Jan; 32(1):91-100. PubMed ID: 7678197
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Generation of monoclonal antibodies of desired specificity using chimeric polyomavirus-derived virus-like particles.
    Zvirbliene A; Samonskyte L; Gedvilaite A; Voronkova T; Ulrich R; Sasnauskas K
    J Immunol Methods; 2006 Apr; 311(1-2):57-70. PubMed ID: 16516908
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HLA-DR and -DQ epitopes and monoclonal antibody specificity.
    Marsh SG; Bodmer JG
    Immunol Today; 1989 Sep; 10(9):305-12. PubMed ID: 2480137
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The monoclonal antibody HCA2 recognises a broadly shared epitope on selected classical as well as several non-classical HLA class I molecules.
    Seitz C; Uchanska-Ziegler B; Zank A; Ziegler A
    Mol Immunol; 1998 Sep; 35(13):819-27. PubMed ID: 9839550
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular characterization of major histocompatibility complex class II gene expression and demonstration of antigen-specific T cell response indicate a new phenotype in class II-deficient patients.
    Hauber I; Gulle H; Wolf HM; Maris M; Eggenbauer H; Eibl MM
    J Exp Med; 1995 Apr; 181(4):1411-23. PubMed ID: 7699327
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development, characterization, and epitope mapping of a panel of twenty-four monoclonal antibodies specific for human inducible nitric oxide synthase.
    Webber RJ; Rodriguez JG; Webber DS; Dunnebacke TH
    Hybridoma (Larchmt); 2005 Feb; 24(1):6-13. PubMed ID: 15785204
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fine specificity of high molecular weight-melanoma-associated antigen-specific cytotoxic T lymphocytes elicited by anti-idiotypic monoclonal antibodies in patients with melanoma.
    Murray JL; Gillogly M; Kawano K; Efferson CL; Lee JE; Ross M; Wang X; Ferrone S; Ioannides CG
    Cancer Res; 2004 Aug; 64(15):5481-8. PubMed ID: 15289358
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Production and characterization of chimeric anti-HLA monoclonal antibodies targeting public epitopes as tools for standardizations of the anti-HLA antibody detection.
    Congy-Jolivet N; Drocourt D; Portet S; Tiraby G; Blancher A
    J Immunol Methods; 2013 Apr; 390(1-2):41-51. PubMed ID: 23352853
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of in vitro and in vivo anticanine T lymphocyte and anticanine class II-specific monoclonal antibodies in the beagle.
    Fuller L; Esquenazi V; Carreno M; Alejandro R; Pardo V; Roth D; Schultz D; Olson L; Milgrom M; Miller J
    Transplantation; 1988 Mar; 45(3):591-600. PubMed ID: 2964746
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlations between Terasaki's HLA class II epitopes and HLAMatchmaker-defined eplets on HLA-DR and -DQ antigens.
    Marrari M; Duquesnoy RJ
    Tissue Antigens; 2009 Aug; 74(2):134-46. PubMed ID: 19497040
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HLA antibody responses in HLA class I transgenic mice.
    Tahara T; Yang SY; Khan R; Abish S; Hämmerling GJ; Hämmerling U
    Immunogenetics; 1990; 32(5):351-60. PubMed ID: 2249882
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Complexity of the supertypic HLA-DRw53 specificity: two distinct epitopes differentially expressed on one or all of the DR beta-chains depending on the HLA-DR allotype.
    Knowles RW; Flomenberg N; Horibe K; Winchester R; Radka SF; Dupont B
    J Immunol; 1986 Oct; 137(8):2618-26. PubMed ID: 2428870
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association between HLA class II genes and autoantibodies to cyclic citrullinated peptides (CCPs) influences the severity of rheumatoid arthritis.
    van Gaalen FA; van Aken J; Huizinga TW; Schreuder GM; Breedveld FC; Zanelli E; van Venrooij WJ; Verweij CL; Toes RE; de Vries RR
    Arthritis Rheum; 2004 Jul; 50(7):2113-21. PubMed ID: 15248208
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recognition of HLA class II molecules by antipeptide antibodies elicited by synthetic peptides selected from regions of HLA-DP antigens.
    Chersi A; Houghten RA; Morganti MC; Muratti E
    Z Naturforsch C J Biosci; 1987; 42(11-12):1313-8. PubMed ID: 2966503
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human leukocyte antigen class II DQ alpha and beta epitopes identified from sera of kidney allograft recipients.
    Deng CT; El-Awar N; Ozawa M; Cai J; Lachmann N; Terasaki PI
    Transplantation; 2008 Aug; 86(3):452-9. PubMed ID: 18698250
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.